One of the world's largest corporations, Eli Lilly and Company (NYSE: LLY (http://www.nyse.com/about/listed/lcddata.html?ticker=LLY)) is a global pharmaceutical company with headquarters in Indianapolis,Indiana, USA. A Fortune 500 corporation, the company had revenues of $12.5 billion in 2003. The company is publicly traded on the New York Stock Exchange and is a member of the S&P 500 stock index.
EliLilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives.
Lilly is the first pharmaceutical company to disclose its grants to U.S. organizations, which include medical societies, academic centers, patient groups and non-profit institutions.
Lilly announced the creation of an ambitious public-private partnership to conduct early-phase discovery research of new medicines urgently needed to treat tuberculosis (TB), including emerging resistant strains.
EliLilly is one of the Nifty Fifty stocks that propelled the late 20th century bull market.
EliLilly is a leading global manufacturer and distributor of pharmaceutical therapies for cancer, cardiovascular disease, central nervous system, diabetic and endocrine system disorders, infectious diseases, and other diagnoses.
EliLilly was the first distributor of methadone, an analgesic used frequently in the treatment of heroin, opium and other opioid and narcotic drug addictions.
Feeds |
Contact